|
시장보고서
상품코드
2054187
세포배양 시약 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 세포 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Cell Culture Reagents Market Size, Share, and Growth Analysis, By Product Type (Media, Sera), By Cell Type (Mammalian Cells, Stem Cells), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 세포배양 시약 시장 규모는 2024년에 32억 달러로 평가되며, 2025년 35억 6,000만 달러에서 2033년까지 83억 7,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 11.28%로 성장할 것으로 전망되고 있습니다.
전 세계 세포배양 시약 시장은 주로 급성장하고 있는 바이오의약품 연구 및 세포 기반 치료제 분야에 의해 주도되고 있습니다. 이러한 분야에서는 신약 개발 및 제조 공정에서 신뢰할 수 있는 배지, 혈청 대체제, 성장인자 및 보조 시약이 요구되고 있습니다. 배지, 보충제, 혈청 대체제, 효소 등으로 구성된 이 시장에서 실험의 재현성과 규제 당국의 승인을 확보하기 위해서는 품질이 매우 중요합니다. 특히 단일클론 항체나 CAR-T 세포의 증식 과정에서, 동물 혈청에 대한 의존도를 줄이기 위해 화학적으로 정의된 무혈청 제제로의 전환이 진행되고 있습니다. 또한 규제 요건의 강화와 기술의 발전이 시장 구조를 변화시키고 있으며, 소규모 공급업체에게는 어려움이 되고 있는 반면, 규제를 준수하는 제품에는 높은 가격을 책정할 수 있게 되었습니다. AI 통합을 통해 예측 설계 및 워크플로 최적화를 바탕으로 혁신이 촉진되어, 궁극적으로 세포배양 시약의 개발 및 조달 효율이 향상되고 있습니다.
세계 세포배양 시약 시장의 성장 요인
전 세계 세포배양 시약 시장의 주요 성장 동인 중 하나는 바이오의약품에 대한 수요 증가입니다. 만성질환의 증가와 혁신적인 치료법에 대한 수요에 힘입어 바이오의약품 산업이 확대됨에 따라 첨단 세포배양 기술과 시약에 대한 수요가 필수적이어지고 있습니다. 이러한 시약은 의료 과제 해결에 지극히 중요한 역할을 하는 백신, 항체 및 기타 생물제제의 개발과 제조에 필수적입니다. 또한 맞춤형 의료에 대한 관심이 높아지고 있으며, 재생의학과 관련된 연구 활동이 급증하고 있는 점도 세포배양 시약의 도입을 더욱 촉진하고 시장 성장을 이끌고 있습니다.
세계 세포배양 시약 시장의 제약 요인
전 세계 세포배양 시약 시장의 주요 제약 요인 중 하나는 첨단 세포배양 기술 및 시약에 따른 높은 비용입니다. 이로 인해 예산이 제한적인 소규모 연구 기관이나 연구소에서는 이러한 기술 및 시약을 이용하기 어려워질 수 있습니다. 이러한 경제적 장벽은 혁신을 저해하고, 다양한 연구 및 치료 분야에서 이러한 필수 제품의 도입을 지연시킬 우려가 있습니다. 또한 이러한 시약의 제조 및 사용을 규제하는 엄격한 규제 요건은 신규 진입자에게 시장 진입을 더욱 어렵게 만들 수 있습니다. 이러한 요인들이 복합적으로 작용하여 시장 성장을 저해하고, 세포배양 시약 분야에서 사업을 영위하는 기업의 경쟁력을 약화시킬 가능성이 있습니다.
세계 세포배양 시약 시장의 동향
전 세계 세포배양 시약 시장은 바이오의약품, 세포·유전자 치료 및 맞춤형 의료에 대한 수요 증가에 힘입어 인상적인 성장을 달성하고 있습니다. 이러한 추세에 따라 공급업체들은 효율적인 규모 확대와 원활한 기술 이전을 목표로 맞춤형 배지, 첨가제 및 전문 서비스를 포함한 제품 라인업의 다각화를 추진하고 있습니다. 위탁 개발 기관(CDO) 및 학술기관과의 협력을 강화함으로써, 용도에 특화된 제제 개발이 진행되고 있습니다. 그 결과, 고성능이며 재현성이 뛰어난 시약에 대한 수요가 증가하고 있으며, 이는 안정성, 확장성 및 공급망 회복탄력성 분야의 혁신을 촉진하고 있습니다. 이러한 진화는 복잡한 바이오 공정 워크플로우를 간소화하고 전 세계에서 개발 일정을 단축하는 데 필수적입니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 세포배양 시약 시장 규모 : 제품 유형별
세계의 세포배양 시약 시장 규모 : 세포 유형별
세계의 세포배양 시약 시장 규모 : 용도별
세계의 세포배양 시약 시장 규모 : 최종사용자별
세계의 세포배양 시약 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.06.18Global Cell Culture Reagents Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.56 Billion in 2025 to USD 8.37 Billion by 2033, growing at a CAGR of 11.28% during the forecast period (2026-2033).
The Global Cell Culture Reagents Market is primarily driven by the booming biopharmaceutical research and cell-based therapeutics sectors, which demand reliable media, sera alternatives, growth factors, and accessory reagents for discovery and manufacturing processes. Comprising basal media, supplements, sera substitutes, and enzymes, quality in this market is crucial for ensuring experimental reproducibility and regulatory approvals. The trend has shifted from animal serum dependency to chemically defined, serum-free formulations, particularly for monoclonal antibodies and CAR-T expansions. Additionally, increasing regulatory demands and technological advancements are reshaping the landscape, creating challenges for smaller suppliers while enabling premium pricing for compliant products. The integration of AI is enhancing innovation through predictive design and optimized workflows, ultimately improving efficiency in developing and sourcing cell culture reagents.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Culture Reagents Market Segments Analysis
Global cell culture reagents market is segmented by product type, cell type, application, end user and region. Based on product type, the market is segmented into Media, Sera, Reagents & Supplements and Contamination Detection Reagents. Based on cell type, the market is segmented into Mammalian Cells, Stem Cells, Insect Cells, Microbial Cells and Others. Based on application, the market is segmented into Biopharmaceutical Production, Vaccine Production, Drug Discovery & Development, Toxicity Testing, Tissue Engineering & Regenerative Medicine, Cancer Research, Stem Cell Research, Cell & Gene Therapy and Others. Based on end user, the market is segmented into Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), Hospitals & Diagnostic Laboratories and Cell Banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cell Culture Reagents Market
One of the key market drivers for the global cell culture reagents market is the growing demand for biopharmaceutical products. As the biopharmaceutical industry expands, fueled by the rising incidence of chronic diseases and the need for innovative therapies, the requirement for advanced cell culture techniques and reagents becomes critical. These reagents are essential for the development and production of vaccines, antibodies, and other biologics, which are pivotal in addressing healthcare challenges. Additionally, the increasing focus on personalized medicine and the surge in research activities related to regenerative medicine further propel the adoption of cell culture reagents, driving market growth.
Restraints in the Global Cell Culture Reagents Market
One significant market restraint for the global cell culture reagents market is the high cost associated with advanced cell culture technologies and reagents, which can limit accessibility for smaller research institutions and laboratories with constrained budgets. This financial barrier may hinder innovations and slow the adoption of these essential products in various research and therapeutic applications. Additionally, stringent regulatory requirements governing the production and usage of these reagents can further complicate market entry for new players. Together, these factors can restrict market growth and reduce the competitiveness of firms operating in the cell culture reagents domain.
Market Trends of the Global Cell Culture Reagents Market
The Global Cell Culture Reagents market is experiencing significant growth driven by the rising demand for biologics, cell and gene therapies, and personalized medicine. This trend is prompting suppliers to diversify their product offerings, including tailored media, supplements, and specialized services designed for efficient scale-up and seamless technology transfer. Enhanced collaborations with contract development organizations and academic institutions are fostering the creation of application-specific formulations. Consequently, there is a heightened demand for high-performance, reproducible reagents, which is propelling innovation in stability, scalability, and supply chain resilience. This evolution is crucial for streamlining complex bioprocess workflows and expediting development timelines on a global scale.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Cell Culture Reagents Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Media
- Classical Media
- Serum-Free Media
- Specialty Media
- Stem Cell Culture Media
- Chemically Defined Media
- Others
- Sera
- Fetal Bovine Serum (FBS)
- Newborn Calf Serum
- Adult Bovine Serum
- Human Serum
- Others
- Reagents & Supplements
- Growth Factors & Cytokines
- Buffers & Salts
- Antibiotics & Antimycotics
- Amino Acids
- Attachment Factors & Extracellular Matrix Reagents
- Cell Dissociation Reagents
- Cryopreservation Reagents
- Others
- Contamination Detection Reagents
- Mycoplasma Detection Reagents
- Endotoxin Detection Reagents
- Sterility Testing Reagents
Global Cell Culture Reagents Market Size by Cell Type & CAGR (2026-2033)
- Market Overview
- Mammalian Cells
- Stem Cells
- Insect Cells
- Microbial Cells
- Others
Global Cell Culture Reagents Market Size by Application & CAGR (2026-2033)
- Market Overview
- Biopharmaceutical Production
- Vaccine Production
- Drug Discovery & Development
- Toxicity Testing
- Tissue Engineering & Regenerative Medicine
- Cancer Research
- Stem Cell Research
- Cell & Gene Therapy
- Others
Global Cell Culture Reagents Market Size by End User & CAGR (2026-2033)
- Market Overview
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals & Diagnostic Laboratories
- Cell Banks
Global Cell Culture Reagents Market Size & CAGR (2026-2033)
- North America (Product Type, Cell Type, Application, End User)
- US
- Canada
- Europe (Product Type, Cell Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Cell Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Cell Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Cell Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PromoCell GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HiMedia Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellGenix GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Avantor Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pan-Biotech GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyagen Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MP Biomedicals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PeproTech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
